Literature DB >> 9117293

Surgical treatment of giant haemangioma of the liver.

M A Brouwers1, P M Peeters, K P de Jong, E B Haagsma, I J Klompmaker, C M Bijleveld, J H Zwaveling, M J Slooff.   

Abstract

BACKGROUND: The treatment of giant symptomatic haemangioma of the liver is still controversial. This retrospective study reviewed the results of surgical treatment.
METHODS: Twenty-eight patients with symptomatic giant haemangioma of the liver were treated by liver resection (n = 24) or liver transplantation (n = 4). The median diameter of the haemangiomas was 11 (range 5-20) cm.
RESULTS: Complications occurred in five of the 24 patients treated by partial liver resection, although all survived and remain alive and well more than 2 years after surgery. In six patients there was residual haemangioma in the liver remnant which did not enlarge during the 2-year follow-up. In four patients the haemangioma was considered irresectable and liver transplantation was performed. One died after a 'two-stage' liver transplantation; the remaining three patients are alive and well, 1, 4 and 9 years after transplantation.
CONCLUSION: Liver resection is the treatment of choice for giant haemangioma of the liver where possible. In selected cases liver transplantation is indicated.

Entities:  

Mesh:

Year:  1997        PMID: 9117293

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  31 in total

1.  Superselective Transarterial Chemoembolization as an Alternative to Surgery in Symptomatic/Enlarging Liver Hemangiomas.

Authors:  İlgin Özden; Arzu Poyanlı; Yılmaz Önal; Ali Aslan Demir; Gültekin Hoş; Bülent Acunaş
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

2.  Enucleation of centrally located giant hepatic hemangioma: report of two cases.

Authors:  Selcuk Mevlut Hazinedaroglu; Huseyin Ayhan Kayaoglu; Mehmet Ali Yerdel
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

Review 3.  [Ultrasound contrast agents for liver diagnostics].

Authors:  A-J Lemke; S S Chopra; S M Niehues; R Felix
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

Review 4.  Has laparoscopy increased surgical indications for benign tumors of the liver?

Authors:  Adriana Toro; Michel Gagner; Isidoro Di Carlo
Journal:  Langenbecks Arch Surg       Date:  2012-10-09       Impact factor: 3.445

5.  Giant liver hemangioma: therapy by enucleation or liver resection.

Authors:  Erhan Hamaloglu; Hasan Altun; Arif Ozdemir; Ahmet Ozenc
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

6.  Orthotopic liver transplantation for giant liver haemangioma: A case report.

Authors:  Undine G Lange; Julian N Bucher; Markus B Schoenberg; Christian Benzing; Moritz Schmelzle; Tanja Gradistanac; Steffen Strocka; Hans-Michael Hau; Michael Bartels
Journal:  World J Transplant       Date:  2015-12-24

7.  Surgical treatment of giant liver hemangiomas: enucleation with continuous occlusion of hepatic artery proper and intermittent Pringle maneuver.

Authors:  Feng Xia; Wan-Yee Lau; Cheng Qian; Shuguang Wang; Kuansheng Ma; Ping Bie
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

8.  Enucleation versus hepatectomy for giant hepatic haemangiomas: a meta-analysis.

Authors:  W L Cheng; Y Q Qi; B Wang; L Tian; W Huang; Y Chen
Journal:  Ann R Coll Surg Engl       Date:  2016-11-21       Impact factor: 1.891

9.  Management of hemangioma of the liver: surgical therapy or observation?

Authors:  Süleyman Yedibela; Sedat Alibek; Volker Müller; Unal Aydin; Melanie Langheinrich; Clemens Lohmüller; Werner Hohenberger; Aristotelis Perrakis
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

10.  Hepatic resection for benign non-cystic liver lesions.

Authors:  D L Clarke; E J Currie; K K Madhavan; R W Parks; O J Garden
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.